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MRI‑based in vivo detection 
of coronary microvascular 
dysfunction before alterations 
in cardiac function induced 
by short‑term high‑fat diet in mice
Grzegorz Kwiatkowski1, Anna Bar1, Agnieszka Jasztal1 & Stefan Chłopicki1,2*
Endothelial dysfunction is one of the hallmarks of vascular abnormalities in metabolic diseases and 
has been repeatedly demonstrated in coronary and peripheral circulation in mice fed high‑fat diet 
(HFD), particularly after long‑term HFD. However, the temporal relationship between development 
of coronary microvascular endothelial dysfunction and deterioration in diastolic and systolic cardiac 
function after short‑term feeding with HFD has not yet been studied. This study aimed to correlate 
the changes in coronary microvascular endothelial function and global cardiac performance indices 
in vivo after short‑term feeding with HFD in mice. Short‑term feeding with a HFD (60% fat + 1% 
cholesterol) resulted in severely impaired coronary microvascular function, as evidenced by the 
diminished effect of nitric oxide synthase inhibition (by L‑NAME) assessed using  T1 mapping via 
in vivo MRI. Deterioration of coronary microvascular function was detected as early as after 7 days of 
HFD and further declined after 8 weeks on a HFD. HFD‑induced coronary microvascular dysfunction 
was not associated with impaired myocardial capillary density and was present before systemic 
insulin resistance assessed by a glucose tolerance test. Basal coronary flow and coronary reserve, 
as assessed using the  A2A adenosine receptor agonist regadenoson, were also not altered in HFD‑
fed mice. Histological analysis did not reveal cardiomyocyte hypertrophy or fibrosis. Increased lipid 
accumulation in cardiomyocytes was detected as early as after 7 days of HFD and remained at a similar 
level at 8 weeks on a HFD. Multiparametric cardiac MRI revealed a reduction in systolic heart function, 
including decreased ejection rate, increased end‑systolic volume and decreased myocardial strain in 
diastole with impaired ejection fraction, but not until 4 weeks of HFD. Short‑term feeding with HFD 
resulted in early endothelial dysfunction in coronary microcirculation that preceded alteration in 
cardiac function and systemic insulin resistance.
Abbreviations
HFD  High fat diet
IHD  Ischemic heart disease
CMD  Coronary microcirculation disease
L-NAME  Nω-nitro-l-arginine methyl ester hydrochloride
LV  Left ventricle
ESV  End systolic volume
EDV  End diastolic volume
SV  Stroke volume
CO  Cardiac output
EF  Ejection fraction
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Coronary macrocirculation, consisting of the epicardial coronary arteries, has mostly a conductance role and, 
as such, exhibits little resistance to coronary flow when not obstructed. In contrast, coronary microcirculation 
of pre-arterioles and arterioles encloses the majority of the blood within the coronary circulation and comprises 
most of the resistance circuit of the heart. To adapt to varying mechanical workloads, the heart relies on extensive 
vasomotor regulation of both macro- and  microcirculation1. Consequently, any mismatch between vasomotor 
augmentation of coronary microcirculation and increased oxygen demand may lead to diminished blood supply 
to the myocardium and, in turn, to ischaemic  conditions2,3.
Often synonymous with coronary artery disease (CAD), stenosis of epicardial coronary arteries has long been 
recognized as a risk factor for ischaemic heart disease (IHD). However, an emerging body of evidence suggests 
that coronary microvascular dysfunction (CMD) is an important contributor to myocardial ischaemia in both the 
presence and absence of epicardial coronary  atherosclerosis4. Furthermore, CMD is commonly present in patients 
with metabolic derangements and has been reported in various models of metabolic syndrome in  animals5.
There is overwhelming evidence that endothelial dysfunction in large conduit vessels as well as in the micro-
circulation is a hallmark of vascular dysfunction associated with obesity and insulin resistance. Several studies 
have demonstrated compromised endothelial function in conduit vessels in subjects with type I diabetes or type 
II diabetes, pre-diabetic patients and healthy volunteers exposed to prolonged glucose  administration6. Standard 
protocols to assess systemic endothelial dysfunction in humans are based on changes in brachial artery vasomo-
tor function during flow-mediated vasodilation (FMD)7.
The classical method to assess endothelial function in experimental models is based on ex vivo measurements 
of endothelial-dependent responses in large arteries or small arteries, as well as in isolated perfused heart, and 
all of these approaches were used to study impaired endothelial function caused by metabolic derangements 
induced by diabetes or by high fat diet (HFD)8–10.
Recently, an in vivo MRI method was adopted to characterise endothelial function in large or conduit-type of 
 vessels11 and has proven reliable to detect early endothelial dysfunction in the aorta induced by short-term feed-
ing with  HFD12 as well as to detect endothelial dysfunction in vivo in large arteries in various murine  models13–15.
In contrast to endothelial testing of large vessels, quantitative assessment of coronary microvascular function 
in vivo is challenging due to technical difficulties with directly imaging microvascular beds. In particular in small 
experimental animals, probing of the coronary endothelial status requires invasive Doppler wire catheterisation, 
not easily feasible in small animals. Instead, myocardial blood flow quantification under rest and flow-increased 
conditions is used as a surrogate for coronary microvascular  status16,17. Recently, Cui et al.18 demonstrated that 
dynamic cardiac  T1 MRI mapping with subsequent endothelial nitric oxide synthase (eNOS) inhibition with 
Nω-Nitro-l-arginine methyl ester (L-NAME) can provide direct quantification of nitric oxide (NO)-dependent 
function, one of the key mediators regulating endothelial function. By rapidly depleting the local vessel NO pro-
duction, endothelial permeability was altered, leading to changes in water and protein efflux through the vessel 
 lumens19–21. The acute changes in tissue water content were directly probed in vivo via  T1 relaxation mapping, 
and this effect was proportional to eNOS  function18. In this study, taking advantage of the MRI-based method 
proposed by Cui et al.18, as well as other complementary methods, we comprehensively evaluated the temporal 
relationship between the alteration in coronary microcirculation status and deterioration in cardiac function in 
response to short-term feeding with an HFD in mice. Changes in coronary microvascular NO-dependent func-
tion and global LV function and function of the left ventricle were assessed at several time points during a HFD, 
from 3 days to 8 weeks. Furthermore, the coronary blood flow reserve was assessed using Doppler flow velocity 
mapping under basal and hyperaemic conditions. Using this experimental approach, we demonstrated for the 
first time to our knowledge that as few as 7 days of HFD resulted in endothelial dysfunction in coronary micro-
circulation that occurred prior to alterations in cardiac function and systemic insulin resistance in HFD-fed mice.
Results
Insulin resistance and body mass change in mice fed a high‑fat diet for 1–8 weeks. As shown 
in Fig. 1, there were no significant changes in either body mass or results on the glucose tolerance test after 3 and 
7 days on a HFD. However, body mass progressively increased starting from 14 days on a HFD, attaining maxi-
mum values of body mass increase after 8 weeks of HFD feeding, as shown in Fig. 1A. Parallel to a body mass 
change, significant insulin resistance was found starting at 14 days of HFD, but not earlier (i.e. after 3 or 7 days on 
a HFD). After 14 days of HFD a twofold increase in total glucose blood levels (AUC) following glucose infusion 
was found and at t = 8 weeks of HFD, AUC increased almost by threefolds, as shown in Fig. 1B,C.
Coronary microvascular dysfunction in mice fed a high‑fat diet for 1–8 weeks. Intravenous 
injection of 100 mg/kg of L-NAME resulted in significant changes in myocardial  T1 time, as shown in Fig. 2C. In 
a group of animals fed with a standard diet, eNOS inhibition with L-NAME increased  T1 relaxation time, with 
the maximum change occurring at 8 min post-injection and at a value of approximately 15% of baseline  T1 time 
(Fig. 2D,E). A similar time course was observed across all groups of control animals. In contrast, in animals fed 
with a HFD, a significantly smaller increase or even a decrease in  T1 relaxation time was observed after eNOS 
inhibition with L-NAME. Surprisingly, the area under the ΔT1 − post-injection time curve tended to be smaller 
in HFD-fed animals even after only 3 days of HFD, and was significantly smaller after 7 days of HFD (Fig. 2F). 
The severity of coronary microvascular dysfunction, as assessed based on L-NAME response and cumulative 
ΔT1 (Fig. 2F), was similar in magnitude after 7 days, 2 weeks and 4 weeks of HFD, but further deteriorated with 
a HFD duration of 8 weeks.
Coronary microvascular dysfunction in mice fed a high‑fat diet for 1–8 weeks. In order to verify 
whether coronary microvascular dysfunction in mice fed a HFD was associated with the impairment of coro-
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nary flow reserve, the vasodilation response of the coronary artery to regadenoson (1 mg/kg) was probed with 
Doppler flow velocity mapping in control and HFD-fed animals after 7 days on either diet. Examples of blood 
flow speckles recorded at rest and during vasodilation induced by regadenoson are shown in Fig. 3A,B, respec-
tively. Significantly increased blood flow velocity was obtained after regadenoson injection (Fig. 3C,E). This was 
accompanied by an increase in heart rate during the vasodilation protocol (Fig. 3D). No significant differences 
in either peak coronary blood flow reserve (Fig. 3F) or mean blood flow reserve (Fig. 3G) were found between 
control and HFD-fed animals.
Histological evaluation of ex vivo heart tissue samples in mice fed a high‑fat diet for 
1–8 weeks. Standard histological evaluation of cardiac sections obtained from mice at 1, 2 and 8  weeks 
of HFD did not reveal any microscopic alterations in HFD-fed animals compared to controls (Fig. 4A). There 
was also no difference in collagen deposition between control and HFD-fed animals (Fig. 4B). However, HFD 
induced mild but significant myocardial steatosis (4.5–4.8%), which was persistent throughout the duration of 
the diet (Fig. 4C,D). Interestingly, 1 week of HFD feeding resulted in increases in the total number of microvas-
cular vessels and the total vessel lumen area (Fig. 5A–C), as assessed by IHC staining with lectin. This effect was 
not observed after 2–8 weeks of HFD feeding. In contrast, the ratio of vessel lumen to tissue area was decreased 
after 8 weeks of HFD feeding, as shown in Fig. 5D.
Left ventricle global function in mice fed a high‑fat diet for 1–8 weeks. Global LV functional 
analysis is presented in Fig. 6. No significant difference in heart rate was found between the control and HFD-
fed animal at any time point from 3 days to 8 weeks. Similarly, no difference in LV mass was found; however, 
a tendency toward an increase in LV mass was observed after 8 weeks on a HFD (p = 0.08). Stroke volume and 
cardiac output were preserved in HFD mice compared to control mice. Ejection fraction was not reduced after 
up to 2 weeks of HFD feeding, but was reduced after 4 and 8 weeks of HFD feeding compared with control 
animals. A reduction in ejection rate was observed after only 7 days in HFD-fed mice compared to the control 
group (Fig. 7A).
There was no difference in ejection time or isovolumetric contraction time between the two groups (Fig. 7B,C). 
Similarly, there was no difference in filling rate or filling time (Fig. 7D,E). Isovolumetric relaxation time was 
reduced in all HFD-fed groups compared to control animals, but these results were not statistically significant 
(Fig. 7F). End-diastolic volume tended toward an increase at 3 and 7 days on a HFD, while end-systolic volume 
significantly increased at 2–8 weeks on a HFD. Both circumferential  (Ecc) and radial  (Err) peak strain values were 
preserved in HFD-fed mice compared to standard diet-fed animals. Similarly, no difference was found in systolic 
strain rates (systolic/diastolic  SRcc, systolic/diastolic  SRrr). However, as shown in Fig. 8, significant changes in 
diastolic strain values were found at 2 weeks on a HFD, with reduced diastolic  Rcc and reduced diastolic  Rrr values.
Discussion
In this study, taking advantage of an MRI-based method, we demonstrated for the first time to our knowledge 
that coronary microvascular dysfunction is a very early phenomenon in mice fed a HFD and was present after as 
short as 7 days on a HFD. Importantly, coronary microvascular dysfunction induced by short-term feeding with 
HFD was not associated with impaired coronary reserve or with impaired capillary density and occurred prior 
to systemic insulin resistance and alterations in diastolic and systolic cardiac function induced by HFD in mice. 
These findings highlight the relative vulnerability of coronary microvasculature to HFD, but also indicate that 
early development of impaired function of coronary microvasculature may contribute to the cardiomyopathic 
phenotype in metabolic diseases and thus represent an important therapeutic  target2.
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Figure 1.  Effect of a high-fat diet on body mass and insulin resistance. (A) Body mass change (expressed as 
percentage of pre-diet body mass) throughout the diet duration. (B) Blood glucose levels measured at 0, 15, 
30, 45, 60 and 120 min after glucose administration (2 g/kg i.p. (C) Area under the blood glucose level curves 
(AUC) shown in (B). The following number of animals was used: measurements at diet time t = 3 days,  nCTL = 5, 
 nHFD = 6; t = 7 days  nCTL = 5,  nHFD = 8; t = 2 weeks  nCTL = 6,  nHFD = 9; t = 4 weeks  nCTL = 8,  nHFD = 8; t = 8 weeks 
 nCTL = 5,  nHFD = 7.
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In this study, a multiparametric CMR-based in vivo approach was used to comprehensively describe coronary 
microcirculation functional status as well as cardiac global function. In particular, coronary microcirculation 
functional status was directly probed in vivo by measuring  T1 relaxation proportional to eNOS  function18, while 
the assessment of heart function was based not only on the left ventricle systolic/diastolic volume, but also using 
a left ventricle volume–time curve and left ventricle strain analysis, an approach that has previously been shown 
to be sensitive to early changes during  HFD22,23.
The major finding of this study was that the coronary microvascular endothelial phenotype was already 
compromised in pre-insulin-resistant animals. Significant impairment of NO-dependent function was observed 
after 7 days of HFD, and a tendency could already be seen as short period as after 3 days on a diet.
In this study, decrease (in respect to baseline) in endothelial permeability upon L-NAME injection as 
assessed based on T1 mapping was observed for animals fed 2–8 weeks with HFD as compared with control 
animals, while in previous report by Cui et al.24  T1 also increased in response to LNAME in normal mice but 
remained unchanged in HFD mice. This difference could be ascribed to severity of eNOS dysfunction and dose of 




Figure 2.  Assessment of endothelial dysfunction with NOS inhibition and in vivo  T1 mapping. (A) Overview 
of the experimental protocol timing. A variable flip angle  T1 map was obtained using five different RF excitation 
angles and used as a baseline  T1 value. The baseline measurements were followed by 100 mg/kg i.v. L-NAME 
injection, and six continuous post-injection scans with the same RF excitation angle were recorded immediately 
after injection. The post-injection  T1 maps were calculated using the signal changes in post-/pre-injection 
images and the pre-injection  T1 map. (C) Examples of pre-/post-injection  T1 maps (coloured scale, expressed in 
ms) overlaid on anatomical images (greyscale). Time course of changes in  T1 values (expressed as percentage of 
baseline value) after L-NAME injection was calculated as an average over the whole myocardium and obtained 
after 7 days (D) and 8 weeks (E) on a diet. (F) The area under the curve of  T1 change − time curves (cumulative 
ΔT1), * indicates comparison between control and HFD groups at given diet duration time whereas # indicates 
comparison within HFD group. For data in (D–F), results for control animals are given in white and data for 
high-fat diet-fed animals are given in grey. The following number of animals was used: measurements at diet 
time t = 3 days,  nCTL = 5,  nHFD = 6; t = 7 days  nCTL = 5,  nHFD = 8; t = 2 weeks  nCTL = 6,  nHFD = 9; t = 4 weeks  nCTL = 8, 
 nHFD = 8; t = 8 weeks  nCTL = 5,  nHFD = 7.
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dysfunction, observed as diminished endothelial permeability after L-NAME injection, prolonged diet duration 
(12–18 weeks) might have led to more severe coronary endothelial dysfunction. Furthermore, in our study higher 
dose of L-NAME was used (100 vs 4 mg/kg), suggesting more efficient NOS inhibition in vivo, that might have 
translate into more sensitive detection of residual NO-dependent function in coronary circulation of HFD mice.
Previous  studies18 that employed eNOS inhibition with L-NAME also observed that changes in endothelial 
function status precede the changes in myocardial blood flow  reserve18. However, these changes occurred after 
a much longer time on the diet, at week 12 (eNOS dysfunction) and week 18 (perfusion reserve), and early time 
points were not studied. In this study early changes in NO-dependent function did not coincide with impaired 
coronary reserve that was fully preserved. The preserved myocardial blood flow reserve found in this study after 
t = 2 weeks of HFD could be explained by the fact that, unlike in humans, in rodents adenosine A2 receptors 
mediate vasorelaxation only in part through  endothelium25. Moreover, eNOS depletion was shown to trigger 
compensatory mechanism via nNOS and prostacyclin production that preserve adenosine mediated response in 
coronary  flow26. Finally, changes in endothelial permeability could be altered even though endothelium-depend-
ent vasodilation mediated by NO, e.g. induced by flow (flow-mediated dilation, FMD) was fully  preserved27.
In addition, a previous  report8 using isolated coronary arteries from mice fed HFD demonstrated increased 
vasoconstriction and reduced vasodilation responses to acetylcholine infusion compared with control mice, 
accompanied by decreased levels of NO and prostacyclin after 8 weeks of HFD feeding, and number of studies 
demonstrated coronary endothelial dysfunction after long-term  HFD10. Overall, the mechanisms involved in the 
impairment of endothelial function in the coronary artery were ascribed to an increase in oxidative  stress28–30 and 
subsequent eNOS uncoupling, the major hallmark of impaired NO-dependent function of coronary  circulation31 
associated with changes in proinflammatory cytokines and adipose tissue-derived adiponectin levels, increased 
free fatty acid levels and altered cellular  signalling32. Furthermore, long-term feeding with HFD was shown to 
induce significant interstitial  fibrosis33, resulting in extracellular matrix remodelling and stiffening of the ves-
sels, including coronary  arterioles34. However, in our study, no significant fibrosis was found; moreover, cardiac 
histology and myocardial capillary density were not significantly altered after up to 8 weeks of HFD and coronary 
microvascular dysfunction was detected prior to systemic insulin resistance. Furthermore, the early coronary 
microvascular dysfunction was not accompanied by impairment in coronary flow reserve. A decrease in myo-
cardial perfusion capacity was previously reported for rats kept on a HFD for 6  weeks35, but was not observed 
in mice until week 18 on a HFD  diet34.
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Figure 3.  Assessment of in vivo coronary artery flow reserve with Doppler flow velocity measurements. 
Representative examples of coronary blood flow velocity speckles (A) at baseline and (B) 12 min after 1 mg/
kg regadenoson injection. In each case, the speckle waveform was recorded for a fixed time of 800 ms. Note the 
increased number of waveforms recorded after vasodilation compared to the rest condition due to an increased 
heart rate. Time course of (C) absolute blood flow velocity, (D) heart rate and (E) flow reserve recorded 
dynamically after regadenoson injection up to 30 min post-injection. The quantification of the coronary reserve 
was performed with either (F) peak blood velocity reserve or (G) mean blood flow velocity reserve calculated 
between 6 and 18 min post-injection. For data in (F) and (G), results for control mice are given in white, 
whereas data for high-fat diet-fed mice are given in grey. The following number of animals was used  nCTL = 8, 
 nHFD = 8.
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Figure 4.  Histological evaluation of ex vivo heart samples obtained at 1, 2 and 8 weeks on a control and HFD 
diet. Examples of (A) haematoxylin and eosin staining and (B) Picrosirius red (PSR) staining (black arrow 
points towards collagen fibre). (C) Examples of native, bright-field image of Oil Red O (ORO)-stained sections 
and corresponding segmented images for a sample collected after 8 weeks of a diet. (D) Quantitative analysis 
of lipid droplets in ORO-stained section calculated with segmented images as shown in (C). The percentage of 
the area with lipid droplets was obtained as a ratio of lipid content area to total tissue sample area. The following 
number of animals was used  nCTL = 5,  nHFD = 5 for each time point for diet duration.
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Altogether, our results support the hypothesis that compromised NO-dependent function in coronary micro-
circulation is the driving force behind the early coronary microvascular  dysfunction36,37. In this study, early 
coronary microvascular dysfunction was associated with a significant myocardial lipid accumulation that was 
observed for the duration of the HFD. Other studies of HFD also reported myocardial metabolic lipid  toxicity38 
and lipid tissue content  remodelling22, suggesting that excessive lipid accumulation might contribute to early 
coronary microvascular dysfunction and subsequent alterations in cardiac function. Given the primary role 
of endothelia as gatekeepers of cardiac  metabolism39, it is tempting to speculate that coronary microvascular 
dysfunction contributes to cardiac metabolic alterations and to functional impairment in cardiac function as a 
result of dysfunctional delivery of nutrients and hormones to cardiac  cells39.
Although we did not study a possible mechanistic link between coronary microvascular dysfunction and 
cardiac dysfunction here, we demonstrated clearly the temporal relationship between these two phenomena. 
To the best our knowledge, our study was the first to unequivocally demonstrate in vivo that early endothelial 
dysfunction in coronary microcirculation preceded alteration in cardiac function in mice fed a HFD. Indeed, 
early endothelial dysfunction in coronary microcirculation was already detected after 7 days of HFD, yet global 
heart function, as assessed by measuring the change in ejection fraction, was compromised later in the diet 
duration, starting at 4 weeks.
Multiple  studies40 have described the effect of a HFD on cardiac function in mice, with a consensus that 
long-term HFD leads to cardiac  hypertrophy41,  fibrosis42, diastolic  dysfunction38 and impairment in coronary 
flow  reserve34, though the extent of the impairment of systolic cardiac function depended on the exact diet 
composition and diet  duration9,23,43. Indeed, conflicting results regarding early cardiac dysfunction in HFD-fed 
animals exist in the  literature9,44–46. In some reports, mice fed short-term (5 weeks) on a HFD  showed22 early 
signs of reduced myocardial contractility, similar to the data presented in our study. On the other hand, in most 
of the studies, diastolic dysfunction was detected only after long-term  HFD38. In our work, subtle alterations 
in diastolic circumferential and radial strain values were found after as short as 2 weeks of HFD. Interestingly, 
signs of diastolic dysfunction faded thereafter with HFD feeding, suggesting early triggering of compensatory 
 mechanisms47. In our study, a standard 60% HFD was supplemented with 1% cholesterol, which could have 
accelerated the detrimental effects of coronary microvascular dysfunction and diastolic cardiac  dysfunction12,48.
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Figure 5.  Effects of the high-fat diet on coronary microvascular capillary morphology as assessed by ex vivo 
lectin-based immunohistochemical staining. (A) Examples of stained bright-field images obtained at 1, 2 and 
8 weeks on a diet. The black arrow points toward a perpendicular cross-section of the vessel lumen. (B) Total 
number of vessels receded in the whole field of view, (C) total vessel lumen (of only vessels placed perpendicular 
to the imaging field) and (D) the ratio of vessel lumen area to tissue area. The following number of animals was 
used  nCTL = 5,  nHFD = 5 for each diet duration time point.
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Interestingly, it has recently been demonstrated that accelerated impairment of cardiac function during HFD 
could be obtained using the so-called “double hit” approach, in which matured animals (aged 16–20 months) are 
exposed to either HFD alone or HFD + L-NAME49/Angiotensin  II50. Such combinations allowed the development 
of a murine model of diastolic heart failure that closely resembles the clinical description of heart failure with 
preserved ejection fraction, but still requires a prolonged HFD duration (15–20 weeks). Using our MRI-based 
methodology, we were able to detect coronary microvascular dysfunction and subsequent alterations in cardiac 
function with short-term HFD (60% HFD + 1% cholesterol) feeding, offering an attractive alternative methodo-
logical approach to study the effectiveness of novel therapeutic strategies to mitigate coronary microvascular 
dysfunction and subsequent cardiac  dysfunction51,52.
Considering that eNOS plays a crucial role in sustaining microvascular endothelial homeostasis and con-
tributes to vasoprotection, inhibition of platelet aggregation and leukocyte adhesion, in vivo monitoring of 
eNOS function might be indispensable in the further development of basic and clinical research for effective 
endothelium-guided  therapy53,54. A potential replacement for L-NAME injection is applying  T1 mapping dynami-
cally during vasodilation, in which increased blood flow stimulates NO production and can alter microvascular 
endothelial  permeability55.
In conclusion, using MRI-based methodology in vivo, we demonstrated that short-term feeding with a HFD 
triggers early coronary microvascular dysfunction that precedes changes in global heart function, emphasising 
the high vulnerability of coronary microvasculature to HFD-induced insult. Therefore, coronary microvascu-
lature constitutes the locus minoris resistantiae of the cardiometabolic diseases that require targeted therapeutic 
interventions.
Conclusion
Short-term (3 days–8 weeks) feeding with a HFD triggers early impairment of endothelial microvascular status 
















































































Figure 6.  Estimates of LV global function during diet duration. (A) Heart rate, (B) LV mass, (C) End-Systolic 
Volume, (D) End-Diastolic Volume, (E) Stroke Volume, (F) Cardiac Output, and (G) Ejection Fraction obtained 
from LV volume CINE imaging segmentation. The white -control group, grey—HFD group. The following 
number of animals was used: measurements at diet time t = 3 days,  nCTL = 5,  nHFD = 6; t = 7 days  nCTL = 5,  nHFD = 8; 
t = 2 weeks  nCTL = 6,  nHFD = 9; t = 4 weeks  nCTL = 8,  nHFD = 8; t = 8 weeks  nCTL = 5,  nHFD = 7.
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Methods
Animal handling. A total of 48 C57BL/6 mice (10–14-week-old males weighing 25–35 g, obtained from 
Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland) were included in this 
study. The animals were randomly assigned to one of two experimental groups and fed either a HFD (60% kcal 
from fat + 1% cholesterol; ZooLab, Krakow, Poland) or a control diet (AIN93G). The animals were kept on the 
diet for 3, 7, 14, 28 or 56 days. The size of each experimental group is reported in the legends of the correspond-
ing graphs. The animals were housed under a 12 h light/dark cycle in pathogen-free conditions with ad libitum 
access to food and water. All animal experiments were performed in adherence with the Local Ethics Committee 
of Jagiellonian University (Krakow, Poland) and in accordance with the Guide for the Care and Use of Labora-
tory Animals of the National Academy of Sciences (NIH publication No. 85–23, revised 1996), as well as the 
Guidelines for Animal Care and Treatment of the European Community. All results concerning experiments on 
animals follows the recommendations in the ARRIVE guidelines.
Glucose tolerance test. Mice were fasted for 4 h with access to water. Glucose levels were measured using 
a standard glucometer in a drop of blood from the tail, cut at the top. The measurements were taken before and 
after 15, 30, 45, 60 and 120 min of intraperitoneal glucose administration (2 g/kg b.w.). For quantification, area 
under the blood glucose concentration–time curve (AUC) was calculated.
Magnetic resonance imaging. For imaging, the animals were placed in a prone position, with the heart 
in the centre of the detection coil. Anaesthesia was delivered via a nose cone at a constant level of 1.75% iso-
flurane in a mixture of 0.4 l/min  O2: 0.8 l/min air. Body temperature was monitored with an endorectal probe 
and maintained in the range of 35.5–36.5 °C. All MR experiments were recorded with a 9.4 T small animal MRI 
scanner (Bruker BioSpec, Ettlingen, Germany) equipped with a 1000 mT/m gradient coil with a maximum slew 
rate of 3500 T/m/s. A 36 mm quadrature volume coil was used for RF excitation and detection. To evaluate the 
global function of LV, the bright-blood cine images were collated in 6–7 contiguous slices covering the whole 
ventricle volume using a flow-compensated, prospectively gated gradient-echo FLASH sequence with the fol-
lowing parameters: FOV 30 × 30  mm2, acquisition matrix: 192 × 192, TE/TR = 2.3/5 ms, slice thickness = 1 mm, 
number of averages = 4, flip angle  =   11°.   Depending on the heart rate, between 22 and 24 cine frames were 
acquired. The filling and ejection rates of LV were obtained with a high-frame-rate, retrospectively gated cine 
FLASH sequence (IgFLASH) in a mid-ventricular, short-axis slice. The following acquisition parameters were 
used: FOV 30 × 30 mm, acquisition matrix 128 × 128, TE/TR = 1.3/4.2 ms, slice thickness = 1 mm, number of 
repetitions = 1200, flip angle = 11°. The data were reconstructed to 60 frames per cardiac cycle using a vendor-
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Figure 7.  Assessment of LV systolic (A–C) and diastolic (D–F) function based on LV volume-time curve 
analysis obtained in control, standard diet-fed mice (white) and high-fat diet-fed mice (grey). The LV 
function was quantified using LV cavity ejection (A) and filling (D) rates, ejection and filling times (B,E) 
and isovolumetric contraction (C) and relaxation (F) times. Data in (B), (C), (E) and (F) are expressed as a 
percentage of normalised cardiac cycle length. The following number of animals was used: measurements at diet 
time t = 3 days,  nCTL = 5,  nHFD = 6; t = 7 days  nCTL = 5,  nHFD = 8; t = 2 weeks  nCTL = 6,  nHFD = 9; t = 4 weeks  nCTL = 8, 
 nHFD = 8; t = 8 weeks  nCTL = 5,  nHFD = 7.
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using a double-gated FLASH sequence (TE/TR 1.5/4.8 ms, flip angle 11°, FOV 30 × 30     mm2, matrix 192 × 192, 
slice thickness 1.0 mm, 16 repetitions, 20–25 frames) with a spatial modulation of magnetization (SPAMM) 
module for tag generation (square tags: line thickness 0.2 mm, span 0.6 mm).
Myocardial  T1 mapping was performed with a variable flip angle (VFA)56 before and after i.v. injection of 
100 mg/kg Nω-Nitro-l-arginine methyl ester hydrochloride (L-NAME, Sigma Aldrich, Poznan, Poland). The 
pre-injection map was obtained with five RF flip angles of 2°, 5°, 8°, 11° and 13° and RF-spoiled retrospectively 
gated GRE FLASH sequence (IntraGate, Bruker Bio Spin, Ettlingen, Germany) with the following acquisition 
parameters: FOV 30 × 30  mm2, acquisition matrix: 192 × 128, TE/TR = 1.6/10 ms, partial echo = 75%, slice thick-
ness = 1 mm, number of repetitions = 300, with the navigators signal derived from slice refocusing signal and 
reconstructed to six cardiac cycle frames. The total acquisition time for each RF flip angle was 4 min. The post-
injection maps were obtained with a single RF flip angle of 13°, and imaging and  T1 values were derived based on 
the single changes between the pre-/post-injection values and the pre-injection  T1 map (as shown in Fig. 2A,B). 
An average over the whole myocardium was taken as the pre-injection  T1 value.
Coronary artery flow reserve assessment. A separate cohort of animals was used for coronary artery 
blood flow velocity mapping during rest and maximal vasodilation. A Doppler Flow Velocity System (Indus 
Instruments, Texas, USA) equipped with a single transceiver 20 MHz Doppler probe was used. Anaesthesia was 
delivered via a nose cone at a level of 1.5–1.25% isoflurane in a mixture of 40%  O2:80% air. The animals were 
placed in a supine position on a heating pad and secured to a four-channel ECG system with tape on each paw. 
An endorectal probe was inserted for continuous body temperature monitoring. A cannula was placed into a 
tail vein for injection of a vasodilator (1 mg/kg regadenoson). The upper chest was shaved with an electric razor 
and ultrasound gel was applied to both the chest and the Doppler probe. The probe was manually adjusted and 
secured with a micromanipulator. The correct position of the probe along the coronary artery was confirmed 
with a visual inspection of the blood flow velocity waveform and its relation to the ECG  signal57. At each time 
point, blood flow velocity was recorded for 2000 ms, comprising 16–20 blood flow speckles. Speckles recorded 
during expiration were included in the analysis, and the average overall speckles were taken at the maximum 
value of blood flow velocity. The measurements were recorded before and 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 16, 18, 
20, 25 and 40 min post-injection. Coronary flow reserve was calculated as the ratio between blood flow veloc-
ity after regadenoson injection to a pre-injection value. Each animal received a single injection with a constant 
volume of 100 µl.
 CTL, Ecc  HFD, Ecc
 CTL, Err  HFD, Err 
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Figure 8.  Left ventricle circumferential  Ecc (B–E) and radial  Err (F–I) deformation assessment with strain 
MR tagging analysis obtained for control animals (white) and HFD-fed animals (grey). (A)  Ecc/Err strain 
curves recorded for all animals. Maximum deformation (peak  Ecc/Err—B,F) and respective peak strain rates 
at systole (D,H) and diastole (E,I) were calculated from strain–time curves averaged over eight myocardial 
sectors. For evaluation of strain values in diastole, strain values at 1/3 of diastole were taken (C,G). Strain rates 
were calculated with respect to normalised cardiac cycle length. The following number of animals was used: 
measurements at diet time t = 3 days,  nCTL = 5,  nHFD = 6; t = 7 days  nCTL = 5,  nHFD = 8; t = 2 weeks  nCTL = 6,  nHFD = 9; 
t = 4 weeks  nCTL = 8,  nHFD = 8; t = 8 weeks  nCTL = 5,  nHFD = 7.
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Data reconstruction and analysis. A time-volume curve (TVC) was calculated from LV volumes (includ-
ing papillary muscles) assessed using short-axis slice-by-slice semiautomatic segmentation (Segment; Medviso). 
End-systolic (ESV) and end-diastolic (EDV) volumes, stroke volume (SV), ejection fraction (EF), cardiac output 
(CO) and cardiac index [CI x CO/body surface area (BSA); BSA = 9.822 × (body weight), 2/3] were assessed 
from the TVC. A piecewise linear regression (PLR) implemented in MATLAB 2021a (MathWorks), as described 
 previously58,59 was used to obtain ejection (ER) and filling rates (FR), with slopes of segments fitted by PLR 
normalised to the individual SV and RR intervals. Durations of ejection (ET), isovolumic relaxation (IVRT), 
filling (FT) and isovolumic contraction phases (IVCT) were taken from the PLR model and normalised to the 
RR interval. For tagged images analysis, image  registration62 was performed using a dedicated strain analysis 
plug-in using the freely available software Segment (Medviso, http:// segme nt. heibe rg. se)61. The midlevel strain 
maps were used to compute radial  (Err) and circumferential  (Ecc) strains (peak strain). Strains were assessed in 
eight consistent segments encircling the myocardial cross-section and then averaged.
Quantification of  T1 changes in response to NOS inhibition was obtained as the area under the curve of ΔT1 
– post-injection time (cumulative ΔT1).
Doppler flow velocity data were analysed using vendor-provided software (Doppler Signal Processing, Indus 
Instruments, Texas, USA), with a peak blood velocity of 12–16 speckles averaged for each time point.
Histological analysis of myocardial tissue samples. Formalin-fixed and paraffin-embedded or 
30% sucrose-fixed heart samples were used for histological analysis. Haematoxylin and eosin (H&E) staining 
was used for microscopic anatomy differentiation, Picrosirius red (PSR) was used for collagen imaging and 
immunohistochemical (HC) staining with lectin was used for the assessment of capillary density, as described 
 previously13,60. For cardiomyocyte steatosis, myocardial sections were stained with Oil Red O (ORO). Quantita-
tive analysis of stained images was obtained via image segmentation adopted in Ilastik (developed by the Ilastik 
team, with the partial financial support of the Heidelberg Collaboratory for Image Processing, HHMI Janelia 
Farm Research Campus and CellNetworks Excellence Cluster).
Statistical analysis. All data are expressed as mean ± standard deviation (SD). Data from animals fed with 
a control diet or HFD for a given time were compared using a t-test for independent groups. The normality 
of distribution and homogeneity of variance were tested using the Shapiro–Wilk and Brown–Forsythe tests, 
respectively. If these assumptions were not fulfilled, the nonparametric Mann–Whitney U-test was performed. 
Results were considered statistically significant at p < 0.05, with the following notation used: *p < 0.05, **p < 0.01, 
***p < 0.001.
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